Hodgkin lymphoma trials in Brazil

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

  Where

  Curitiba, São Paulo

  Age

  18 years and over

  People

  280 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07519772 · EU 2025-523005-15-00
• Phase 2Taking people
  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Where

  Porto Alegre, São Paulo

  Age

  18 years and over

  People

  270 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06526793 · EU 2023-505789-27-00
• Phase 1/2Taking people
  AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  Where

  São Paulo

  Age

  12 years and over

  People

  161 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06137144 · EU 2023-506747-42-00
• Phase 1/2Taking people
  A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  Where

  São Paulo

  Age

  6 months to 17 years

  People

  370 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT02332668 · EU 2022-501257-36-00
• Phase 1/2Taking people
  PTCy and ATG for MSD and MUD Transplants

  Where

  Rio de Janeiro

  Age

  18 years to 60 years

  People

  50

  Run by

  Instituto Nacional de Cancer, Brazil

  See details and how to joinNCT06299462